Our study highlights the reduction of CD8+CD226+ T cells in CLL patients, particularly in advanced Rai stages and unmutated IgVH cases, which correlates with a poor clinical prognosis. The gene discussed is CD226; the disease is B-cell chronic lymphocytic leukemia.